Overview

Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare the efficacy of the Levonorgestrel releasing Intrauterine System (Mirena) and Norethisterone Acetate for treatment of non-atypical endometrial hyperplasia in perimenopausal women.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mansoura University
Treatments:
Levonorgestrel
Norethindrone
Norethindrone Acetate
Criteria
Inclusion Criteria:

- Patients with histologically confirmed simple or complex endometrial hyperplasia
without atypia

Exclusion Criteria:

- Endometrial hyperplasia with atypia

- Other pathology e.g. patients with fibroids of any size, genital infection, adnexal
abnormality.